Información del artículo
Abstract
Adenosarcoma of the uterus is an unusual mixed tumor, histologically characterized by a benign epithelial component associated with a mesenquimal sarcomatous element. The classical symptom at presentation is vaginal bleeding occasionally associated with pelvic pain. These are low-grade malignant tumors, which need long term follow-up. We present two cases of uterine adenocarcinoma diagnosed in our hospital during the last ten years.
El Texto completo está disponible en PDF
Bibliografía
[1.]
P.B. Clement, R.E. Scully.
Müllerian adenosarcoma of the uterus. A clinicopathologic analysis of 100 cases with a review of the literature.
Hum Pathol, 21 (1990), pp. 363-380
[2.]
H. Kerner, C. Lichbig.
Müllerian adenosarcoma presenting as cervical polyps: a report of seven cases and review of the literature.
Obstet Gynecol, 81 (1993), pp. 655-659
[3.]
J.H. Eichhorn, R.H. Young, P.B. Clement, R.E. Scully.
Mesodermal (müllerian) adenosarcoma of the ovary. A clinicopatho-logic analysis of 40 cases and a review of the literature.
Am J Surg Pathol, 26 (2002), pp. 1243-1258
[4.]
T. Kaku, S.G. Silverberg, F.J. Major.
Adenosarcoma of the uterus: a Gynecologic Oncology Group clinicopathologic study of 31 cases.
Int J Gynecol Pathol, 11 (1992), pp. 75-79
[5.]
J. Moreno, M.S. Caballero, I. Barredo, J.L. Neyro, I. Ocerin, G. del Val.
Adenosarcoma uterino. A propósito de un caso.
Prog Obstet Ginecol, 39 (1996), pp. 691-694
[6.]
M.J. Gast, L.V. Radkins, A.J. Jacobs, D. Gersell.
Mullerian ade-nosarcoma of the cervix with heterologous elements: diagnostic and therapeutic approach.
Gynecol Oncol, 32 (1989), pp. 381-384
[7.]
P.B. Clement, R.E. Scully.
Extrauterine mesodermal (mülle-rian) adenosarcoma. A clinicopathologic analysis of five cases.
Am J Clin Pathol, 69 (1978), pp. 276-283
[8.]
A.G. Ostor, D.W. Fortune.
Benign and low grade variants of mixed Müllerian tumor of the uterus.
Histopathology, 4 (1980), pp. 369-372
[9.]
P. Clement.
Uterine tumors with mixed epithelial and me-senchymal elements.
Histopathology, 41 (2002), pp. 21-27
[10.]
J.E. Mourits, H. Hollema, P.H.B. Willemse.
Adenosarcoma of the uterus following tamoxifen treatment for breast cancer.
Cancer Lett, 101 (1996), pp. 59-66
[11.]
H.K. Lee, S.H. Kim, J.Y. Cho, K.M. Yeon.
Uterine adenofibro-ma and adenosarcoma: CT and MR findings.
J Comput Assist Tomogr, 22 (1998), pp. 314-316
[12.]
C.M. Michener, N.L. Simon.
Ovarian conservation in woman of reproductive age with mullerian adenosarcoma.
Gynecol Oncol, 88 (2003), pp. 463-464
[13.]
J.T. Thigpen, J.A. Blessing, J. Beecham.
Phase II trial of cis-platin as first-line chemotherapy in patients with advanced or recurrent uterine sarcomas: a gynecologic oncology group study.
J Clin Oncol, 9 (1991), pp. 1962-1967
[14.]
M.G. Del Carmen, D. Lovett, A. Goodman.
A case of mülle-rian adenosarcoma of the uterus treated with liposomal do-xorubicin.
Gynecol Oncol, 88 (2003), pp. 456-458
[15.]
G.A. Omura, F.J. Major, J.A. Blessing.
A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas.
Cancer, 52 (1983), pp. 626-629
[16.]
G. Sutton, J.A. Blessing, N. Rosenshein.
Phase II trial of ifos-famide and mesna in mixed mesodermal tumors of the uterus (a gynecologic oncology group study.
Am J Obstet Gy-necol, 161 (1989), pp. 309-312
Copyright © 2004. Elsevier España, S.L.. Todos los derechos reservados
